Latest News
Equity derivatives trader Drew March, who previously spent 10 years at Credit Suisse, is returning to the sell-side with BNP Paribas in New York after stints with hedge funds Squarepoint Capital and Walleye, according to a report by eFinancial Careers.
Ahead of the Hedgeweek US Leadership Summit in New York on 12 September, Gwen Stone (pictured), Operational Due Diligence, Director at K2 Advisors (Franklin Templeton), talks to us about seeing manager relationships as partnerships, the importance of an internal resource and why new managers should focus on scalability.
Citadel has added two former Segantii Capital Management employees – Andrew Pidgeon and Peter Christie – following the closure of the hedge fund firm amid allegations of insider trading against founder Simon Adler and other employees, according to a report by eFinancial Careers.
Hedge funds have flipped their stance on Japan’s currency, turning bullish on the yen for the first time since 2021 following significant turbulence in foreign-exchange markets that disrupted a popular yen carry trade, according to a report by Bloomberg.
A yen-focused carry trade that contributed to recent market turmoil as investors moved to unwind positions following a number of hawkish moves by the Bank of Japan and concerns over the US economy, is attracting renewed interest from hedge funds, according to a report by Bloomberg.
Hedge funds Citadel and DE Shaw significantly reduced their holdings in Nvidia, while Renaissance Technologies and Marshall Wace increased their positions, ahead of the recent stock market downturn, according to a report by the Financial Times.
Trian Fund Management, the US-based activist hedge fund firm led by Nelson Peltz, has cut its stake in British consumer goods giant Unilever, selling approximately 3.8m shares for nearly £181m ($232m), according to a report by Reuters.
Scion Asset Management, the hedge fund firm led by Michael ‘The Big Short’ Burry, increased its investment in Chinese e-commerce and retail giant Alibaba during the second quarter of the year, according to the firm’s latest 13F filings.
Sachem Head Capital Management, the hedge fund firm led by Scott Ferguson, significantly increased its investment in CVS Health Corp during the second quarter amid a 25% drop in the US healthcare company’s stock price, according to a report by Reuters.